Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Complamin
2. Complamine
3. Komplamin
4. Niacinate, Xanthinol
5. Nicotinate, Xanthinol
6. Nicotinate, Xantinol
7. Sadamin
8. Sadamine
9. Teonicol
10. Xanthinol Nicotinate
11. Xantinol Nicotinate
12. Xantinol-nicotinat-ratiopharm
13. Xavin
1. Xanthinol Nicotinate
2. 437-74-1
3. Xantinol Nicotinate
4. Complamin
5. Angioamin
6. Teonicol
7. Complamex
8. Landrina
9. Sadamine
10. Stenalgil
11. Xanidil
12. Vedrin
13. Complamin Retard
14. Xavin
15. Xanthinol Niacinate [usan]
16. Sk 331 A
17. Xantinol Nicotinate [inn]
18. Nsc-113217
19. Xanthinol Niacinate (usan)
20. Mls000028609
21. Sk 331a
22. 8g60h12x2d
23. Nsc113217
24. Nicotinic Acid, Compd. With 3,7-dihydro-7-(2-hydroxy-3-((2-hydroxyethyl) Methylamino)propyl)-1,3-dimethyl-1h-purine-2,6-dione
25. Ncgc00021151-02
26. Angiomin
27. Sadamin
28. Smr000058741
29. 3-pyridinecarboxylic Acid Compd. With 3,7-dihydro-7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)-1,3-dimethyl-1h-purine-2,6-dione (1:1)
30. 7-(2-hydroxy-3-((2-hydroxyethyl)(methyl)amino)propyl)-1,3-dimethyl-1h-purine-2,6(3h,7h)-dione Nicotinate
31. 7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethylpurine-2,6-dione;pyridine-3-carboxylic Acid
32. Xanthinolium Nicotinicum
33. Xantinoli Nicotinas
34. Xantinolo Nicotinato [dcit]
35. 7-{2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl}theophylline, Compound With Nicotinic Acid (1:1)
36. Nicotinic Acid, Compd. With 7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline (1:1)
37. Xantinolo Nicotinato
38. Nicotinate De Xantinol
39. Nicotinato De Xantinol
40. Xantinoli Nicotinas [inn-latin]
41. Einecs 207-115-7
42. Nicotinate De Xantinol [inn-french]
43. Nicotinato De Xantinol [inn-spanish]
44. Methoxylin, Compd. With Nicotinic Acid
45. Nsc 113217
46. Unii-8g60h12x2d
47. Angioamincomplamin
48. Complamin (tn)
49. 7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)theophylline, Compound With Nicotinic Acid (1:1)
50. 7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline, Compound With Nicotinic Acid (1:1)
51. Opera_id_260
52. 7-(3-(n-(2-hydroxyethyl)amino)-2-hydroxypropyl)thiophylline Nicotinate
53. Dsstox_cid_3743
54. Xantinol Nicotinate ,(s)
55. 7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)theophylline Compd. With Nicotinic Acid
56. Dsstox_rid_77178
57. Dsstox_gsid_23743
58. 7- 2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl Theophylline, Compound With Nicotinic Acid (1:1)
59. Mls001148608
60. Mls001424204
61. Mls006010909
62. Schembl121655
63. Chembl1560089
64. Dtxsid0023743
65. Xanthinol Niacinate [mi]
66. Hms2052e09
67. Hms2230j12
68. Hms3371o12
69. Hms3394e09
70. Hy-b1815
71. Xantinol Nicotinate [mart.]
72. Tox21_110866
73. Mfcd00058342
74. S4868
75. Xantinol Nicotinate [who-dd]
76. Akos005267237
77. Ccg-101097
78. Ccg-269063
79. Nc00347
80. Ncgc00164435-01
81. 7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethyl-purine-2,6-dione; Nicotinic Acid
82. As-11613
83. Cas-437-74-1
84. Nicotinic Acid, Compd. With 7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)theophylline(1:1)
85. Db-051164
86. Cs-0013860
87. Ft-0603393
88. D06334
89. E75972
90. A913692
91. Sr-01000000242
92. Q5814478
93. Sr-01000000242-4
94. 3-pyridinecarboxylic Acid Compd. With 3,3-dimethyl-1h-purine-2,6-dione (1:1)
95. (+/-)-7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)theophylline, Compound With Nicotinic Acid (1:1)
96. {7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline,} Compound With Nicotinic Acid (1:1)
97. 3-pyridinecarboxylic Acid & {3,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,} 3-dimethyl-1h-purine-2,6-dione (1:1)
98. 3-pyridinecarboxylic Acid, Compd. With 3, {7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,} 3-dimethyl-1h-purine-2,6-dione (1:1)
99. 3-pyridinecarboxylic Acid,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,3-dimethyl-1h-purine-2,6-dione (1:1)
100. 7-{2-hydroxy-3-[(2-hydroxyethyl)(methyl)amino]propyl}-1,3-dimethyl-2,3,6,7-tetrahydro-1h-purine-2,6-dione; Pyridine-3-carboxylic Acid
101. Nicotinic Acid Compound With 7-(2-hydroxy-3-((2-hydroxyethyl)(methyl)amino)propyl)-1,3-dimethyl-3,7-dihydro-1h-purine-2,6-dione (1:1)
102. Nicotinic Acid, Compd. With {7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline} (1:1)
103. Pyridine-3-carboxylic Acid - 7-{2-hydroxy-3-[(2-hydroxyethyl)(methyl)amino]propyl}-1,3-dimethyl-3,7-dihydro-1h-purine-2,6-dione (1:1)
| Molecular Weight | 434.4 g/mol |
|---|---|
| Molecular Formula | C19H26N6O6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 7 |
| Exact Mass | 434.19138257 g/mol |
| Monoisotopic Mass | 434.19138257 g/mol |
| Topological Polar Surface Area | 152 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 548 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
C - Cardiovascular system
C04 - Peripheral vasodilators
C04A - Peripheral vasodilators
C04AD - Purine derivatives
C04AD02 - Xantinol nicotinate
Market Place
ABOUT THIS PAGE
A Xanthinol Nicotinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Xanthinol Nicotinate, including repackagers and relabelers. The FDA regulates Xanthinol Nicotinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Xanthinol Nicotinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Xanthinol Nicotinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Xanthinol Nicotinate supplier is an individual or a company that provides Xanthinol Nicotinate active pharmaceutical ingredient (API) or Xanthinol Nicotinate finished formulations upon request. The Xanthinol Nicotinate suppliers may include Xanthinol Nicotinate API manufacturers, exporters, distributors and traders.
click here to find a list of Xanthinol Nicotinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Xanthinol Nicotinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Xanthinol Nicotinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Xanthinol Nicotinate GMP manufacturer or Xanthinol Nicotinate GMP API supplier for your needs.
A Xanthinol Nicotinate CoA (Certificate of Analysis) is a formal document that attests to Xanthinol Nicotinate's compliance with Xanthinol Nicotinate specifications and serves as a tool for batch-level quality control.
Xanthinol Nicotinate CoA mostly includes findings from lab analyses of a specific batch. For each Xanthinol Nicotinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Xanthinol Nicotinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Xanthinol Nicotinate EP), Xanthinol Nicotinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Xanthinol Nicotinate USP).
LOOKING FOR A SUPPLIER?
